Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...
Auteurs principaux: | Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1998
|
Documents similaires
-
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
par: Florakis, D, et autres
Publié: (2000) -
Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
par: Monson, J, et autres
Publié: (2001) -
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
par: Frajese, G, et autres
Publié: (2001) -
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
par: Chung, T, et autres
Publié: (2008) -
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
par: Agha, A, et autres
Publié: (2007)